Comparison of mesalazine suppositories in proctitis and distal proctosigmoiditis

Alimentary Pharmacology and Therapeutics

Volumn 11, Issue 6, 1997, Pages 1053-1057

  Gionchetti, P ^a,b   Rizzello, F ^a   Venturi, A ^a   Brignola, C ^a   Ferretti, M ^a   Peruzzo, S ^a   Campieri, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MESALAZINE; SALAZOSULFAPYRIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROCTITIS; RANDOMIZED CONTROLLED TRIAL; RECTAL DRUG ADMINISTRATION; REMISSION; SIGMOIDOSCOPY; SINGLE BLIND PROCEDURE; SKIN IRRITATION; SUPPOSITORY; ULCERATIVE COLITIS;

EID: 0030862269     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1997.00259.x     Document Type: Article

References (13)

1. Sutherland LR, Martin F. 5-aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada. Dig Dis Sci 1987; 32: S64-5.
2. Campieri M, Gionchetti P, Belluzzi A, et al. Optimum dosage of 5-aminosalicylic acid as rectal enemas in patients with active ulcerative colitis. Gut 1991; 31: 929-31.
3. Van Hogezand RA, van Hees PA. van Gorp JP, et al. Doubleblind comparison of 5-aminosalicylic and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis. Aliment Pharmacol Ther 1988; 2: 33-40.
4. Campieri M, Gionchetti P, Belluzzi A. et al. Topical treatment with 5-aminosalicylic acid in distal ulcerative colitis by using a new suppository presentation. A double blind placebo controlled trial. Int J Colorectal Dis 1990; 5: 79-81.
5. Vitti RA, Meyers F, Knight LC, Siegel JA, Malmud LS, Fisher RS. Quantitative distribution of radiolabeled 5-aminosalicylic acid enema in patients with left-sided ulcerative colitis. Dig Dis Sci 1989; 34: 1792-7.
6. Campieri M, Corbelli C, Gionchetti P. et al Spread and distribution of 5-ASA colonic foam and 5-ASA enema in patients with ulcerative colitis. Dig Dis Sci 1992; 37: 1890-7.
7. Williams CM. Haber G, Aquino JA. Double blind, placebocontrolled evaluation of 5-ASA suppositories in active distal proctitis and measurement of extent of spread using 99 Tclabeled 5-ASA suppositories. Dig Dis Sci 1987; 32: S71-5.
8. Campieri M, Gionchetti P, Belluzzi A, et al. 5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? J Clin Gastroenterol 1988; 10: 406-9.
9. Campieri M. De Franchis R, Bianchi Porro G. Ranzi T, Brunetti G, Barbara L. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomised controlled trial. Scand J Gastroenterol 1990; 25: 663-8.
10. Abd-El-Maeboud KH, El-Naggar T, El-Hawi EMM. Mahmoud SAR, Abd-El-Hay S. Rectal suppository: commonsense and mode of insertion. Lancet 1991; 338: 798-800.
11. Ngo Y, Gelinet JM, Ivanovic A, et al. Efficacy of a daily application of mesalazine (Pentasa suppository) with progressive release in the treatment of ulcerative proctitis. A double-blind vs. placebo randomised trial. Gastroenterol Clin Bio 1992; 16: 782-6.
12. Lucidarme D, Marteau P, Foucault M, et al. Efficacy and tolerance of mesalazine suppositories vs. hydrocortisone foam in proctitis. Aliment Pharmacol Ther 1997; 11: 335-40.
13. Truelove SC, Richard WCD. Biopsy studies in ulcerative colitis. Br Med J 1964; 1: 89-92.